Do you use the inhalers by GlaxoSmithKline, LLC, i.e. GSK? Then you must have heard the news. And for those of you who don’t know there is a defect in these inhalers.
According to an FDA statement Inhalers by GSK, GlaxoSmithKline, LLC, was recalled due to a defective delivery system. We are talking about nearly 600,000 Asthma Inhalers. There is a nationwide distribution of the inhalers.
GlaxoSmithKline made a recall of the product voluntarily on April 4, reported by the Asthma and Allergy Foundation of America’s website.
Three impacted lots of Ventolin HFA 200D Inhalers with lot numbers 6ZP9944, 6ZP9848, and 6ZP0003.
Although the defects are not dangerous to them, the users can return them. The reason why they returned them is that the inhalers didn’t have leak rates. According to GSK as a result of the issue, they don’t expect to have an impact on the supply of Ventolin HFA 200D inhalers.
The model of inhalers that had a defect is “Ventolin HFA”, 200 metered inhalations, 90 mcg per actuation, net weight 18 g inhalers, RX only.
Statement by the Company
According to the company, they commit to supplying products that are of high quality. And that their main goal is to have satisfied customers. They regret if the recall caused any inconvenience.
Last week, there was a huge recall of EpiPens after some had defects- to be more accurate 13 lots of products. The EpiPens are known for the injection of epinephrine which is a life-saving function once inserted in the body. Especially, for people that have extreme allergic reactions.
On Friday there was a press release about that. According to the Food and Drug Administration, the recall was made because these devices had a defective part. That may cause the failure of the devices to activate.
For more information watch the video:
Source Pix11
Image Source Knoe